APA (7th ed.) Citation

Li, B., Jia, Z., Huang, Z., Xue, J., Wang, Y., Guo, C., . . . Li, S. (2023). Adjuvant crizotinib treatment selected by patient-derived organoids in a patient with stage IIIA adenocarcinoma with novel LRRTM4-ALK fusion: A case report. Translational Lung Cancer Research, 12(11), . https://doi.org/10.21037/tlcr-23-487

Chicago Style (17th ed.) Citation

Li, Bowen, et al. "Adjuvant Crizotinib Treatment Selected by Patient-derived Organoids in a Patient with Stage IIIA Adenocarcinoma with Novel LRRTM4-ALK Fusion: A Case Report." Translational Lung Cancer Research 12, no. 11 (2023). https://doi.org/10.21037/tlcr-23-487.

MLA (9th ed.) Citation

Li, Bowen, et al. "Adjuvant Crizotinib Treatment Selected by Patient-derived Organoids in a Patient with Stage IIIA Adenocarcinoma with Novel LRRTM4-ALK Fusion: A Case Report." Translational Lung Cancer Research, vol. 12, no. 11, 2023, https://doi.org/10.21037/tlcr-23-487.